天美传媒

Journal of Pharmacokinetics & Experimental Therapeutics
天美传媒 Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

天美传媒 Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Pharmacokinet Exp Ther 9: 288,

Advances in Experimental Therapeutics: Pioneering New Horizons in Oncology Treatment

Divide Gestor*
Department of Pharmacology, Campus de Espinardo, University of Murcia, Spain
*Corresponding Author : Divide Gestor, Department of Pharmacology, Campus de Espinardo, University of Murcia, Spain, Email: dividetor2@gmail.com

Received Date: Jan 01, 2025 / Published Date: Jan 31, 2025

Abstract

The field of oncology has undergone significant transformation with the advent of experimental therapeutics, which focus on innovative approaches for cancer treatment. This review explores cutting-edge therapies and technologies that are reshaping the landscape of cancer care, highlighting novel drug development, targeted therapies, immunotherapies, and personalized medicine. Key strategies, such as gene therapy, CAR T-cell therapies, and the use of artificial intelligence in drug discovery, are examined for their potential to overcome traditional treatment barriers. The promise of these therapies offers new hope for patients with cancers previously deemed untreatable. This article also discusses the challenges and ethical considerations surrounding these emerging therapies, as well as future directions in cancer treatment.

Citation: Divide G (2025) Advances in Experimental Therapeutics: Pioneering New Horizons in Oncology Treatment. J Pharmacokinet Exp Ther 9: 288.

Copyright: 漏 2025 Divide G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 77
  • [From(publication date): 0-0 - Dec 17, 2025]
  • Breakdown by view type
  • HTML page views: 52
  • PDF downloads: 25
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.